vs
Side-by-side financial comparison of Kentucky First Federal Bancorp (KFFB) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Kentucky First Federal Bancorp is the larger business by last-quarter revenue ($2.8M vs $2.2M, roughly 1.3× Instil Bio, Inc.). Kentucky First Federal Bancorp runs the higher net margin — 10.7% vs -365.3%, a 376.1% gap on every dollar of revenue. On growth, Kentucky First Federal Bancorp posted the faster year-over-year revenue change (28.3% vs -19.2%).
Kentucky First Federal Bancorp is a U.S. regional bank holding company based in Kentucky. It offers retail and commercial banking services including deposits, mortgage loans, consumer lending and small business financing, serving local individual customers and small-to-medium enterprises across its Kentucky operating regions.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
KFFB vs TIL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8M | $2.2M |
| Net Profit | $304.0K | $-8.2M |
| Gross Margin | — | — |
| Operating Margin | 14.1% | -426.3% |
| Net Margin | 10.7% | -365.3% |
| Revenue YoY | 28.3% | -19.2% |
| Net Profit YoY | 2238.5% | 31.1% |
| EPS (diluted) | $0.04 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8M | $2.2M | ||
| Q3 25 | $2.7M | $2.2M | ||
| Q2 25 | $2.4M | $2.2M | ||
| Q1 25 | $2.2M | $2.2M | ||
| Q4 24 | $2.2M | $2.8M | ||
| Q3 24 | $2.0M | $1.5M | ||
| Q2 24 | $2.0M | $0 | ||
| Q1 24 | $1.8M | $0 |
| Q4 25 | $304.0K | $-8.2M | ||
| Q3 25 | $344.0K | $-13.6M | ||
| Q2 25 | $176.0K | $-21.4M | ||
| Q1 25 | $7.0K | $-28.2M | ||
| Q4 24 | $13.0K | $-11.9M | ||
| Q3 24 | $-15.0K | $-23.0M | ||
| Q2 24 | $-1.1M | $-14.9M | ||
| Q1 24 | $-107.0K | $-24.3M |
| Q4 25 | 14.1% | -426.3% | ||
| Q3 25 | 17.0% | -670.0% | ||
| Q2 25 | 10.3% | -1045.5% | ||
| Q1 25 | 0.7% | -1363.2% | ||
| Q4 24 | 0.3% | -426.1% | ||
| Q3 24 | -1.0% | -1582.8% | ||
| Q2 24 | -58.7% | — | ||
| Q1 24 | -7.9% | — |
| Q4 25 | 10.7% | -365.3% | ||
| Q3 25 | 12.9% | -606.0% | ||
| Q2 25 | 7.6% | -954.2% | ||
| Q1 25 | 0.3% | -1257.8% | ||
| Q4 24 | 0.6% | -428.8% | ||
| Q3 24 | -0.7% | -1541.9% | ||
| Q2 24 | -56.7% | — | ||
| Q1 24 | -5.8% | — |
| Q4 25 | $0.04 | $-1.13 | ||
| Q3 25 | $0.04 | $-2.01 | ||
| Q2 25 | $0.02 | $-3.24 | ||
| Q1 25 | $0.00 | $-4.32 | ||
| Q4 24 | $0.00 | $-1.82 | ||
| Q3 24 | $0.00 | $-3.54 | ||
| Q2 24 | $-0.13 | $-2.29 | ||
| Q1 24 | $-0.01 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.7M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $49.1M | $113.9M |
| Total Assets | $375.3M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.7M | $6.6M | ||
| Q3 25 | $14.6M | $5.8M | ||
| Q2 25 | $19.5M | $7.7M | ||
| Q1 25 | $27.8M | $15.4M | ||
| Q4 24 | $21.0M | $8.8M | ||
| Q3 24 | $17.3M | $6.7M | ||
| Q2 24 | $18.3M | $6.8M | ||
| Q1 24 | $15.4M | $5.5M |
| Q4 25 | $49.1M | $113.9M | ||
| Q3 25 | $48.8M | $120.4M | ||
| Q2 25 | $48.4M | $131.7M | ||
| Q1 25 | $48.2M | $144.9M | ||
| Q4 24 | $48.1M | $169.4M | ||
| Q3 24 | $48.2M | $176.3M | ||
| Q2 24 | $48.0M | $195.0M | ||
| Q1 24 | $49.0M | $205.8M |
| Q4 25 | $375.3M | $203.5M | ||
| Q3 25 | $366.5M | $211.8M | ||
| Q2 25 | $371.2M | $231.0M | ||
| Q1 25 | $380.7M | $237.4M | ||
| Q4 24 | $374.2M | $263.6M | ||
| Q3 24 | $375.6M | $272.6M | ||
| Q2 24 | $375.0M | $294.3M | ||
| Q1 24 | $369.1M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-303.0K | $-7.1M |
| Free Cash FlowOCF − Capex | $-367.0K | — |
| FCF MarginFCF / Revenue | -12.9% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | -1.00× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-303.0K | $-7.1M | ||
| Q3 25 | $450.0K | $-10.6M | ||
| Q2 25 | $-86.0K | $-14.8M | ||
| Q1 25 | $-155.0K | $-4.2M | ||
| Q4 24 | $1.4M | $-10.6M | ||
| Q3 24 | $-1.4M | $-20.1M | ||
| Q2 24 | $-1.5M | $-10.6M | ||
| Q1 24 | $-176.0K | $-14.4M |
| Q4 25 | $-367.0K | — | ||
| Q3 25 | $445.0K | — | ||
| Q2 25 | $-235.0K | — | ||
| Q1 25 | $-220.0K | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-191.0K | — |
| Q4 25 | -12.9% | — | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | -9.7% | — | ||
| Q1 25 | -9.9% | — | ||
| Q4 24 | 61.8% | — | ||
| Q3 24 | -70.2% | — | ||
| Q2 24 | -77.7% | — | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 6.2% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 3.7% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | -1.00× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | -0.49× | — | ||
| Q1 25 | -22.14× | — | ||
| Q4 24 | 111.31× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
